Trial Profile
Pharmacokinetic drug- drug interaction potential, safety and tolerability of the combination of tropifexor in combination with cenicriviroc
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2018
Price :
$35
*
At a glance
- Drugs Cenicriviroc (Primary) ; Tropifexor (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- 09 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases